Press Releases September 1, 2026 09:09 AM

Hawkins, Inc. Expands in Florida with Acquisition of Dave Symonds & Associates, Inc.

Hawkins, Inc. Strengthens Florida Presence with Acquisition of Water Treatment Distributor Dave Symonds & Associates

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
HWKN

Hawkins, Inc., a Minneapolis-based water treatment and specialty ingredients company, has expanded its operations in Florida by acquiring the assets of Dave Symonds & Associates, a local distributor specializing in blended phosphates for corrosion control and sequestration. This acquisition aligns with Hawkins' strategic growth plans in the Water Treatment segment and broadens its customer reach in the southeastern U.S.

Hawkins, Inc. Expands in Florida with Acquisition of Dave Symonds & Associates, Inc.
HWKN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Hawkins, Inc. has completed a strategic acquisition of Dave Symonds & Associates to expand its water treatment business in Florida.
  • Dave Symonds distributes corrosion control and sequestration products, complementing Hawkins' existing product offerings.
  • The acquisition is a tuck-in deal, enhancing Hawkins' footprint and customer base in the water treatment industry across 28 states.
  • This move supports Hawkins' goal of growing its Water Treatment segment, a key driver of its $1.1 billion revenue in fiscal 2026.

ROSEVILLE, Minn., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Dave Symonds & Associates, Inc. ("Dave Symonds"). Dave Symonds distributes water treatment products, primarily blended phosphates for corrosion control and sequestration, to water treatment customers in Florida.

"The acquisition of Dave Symonds expands our customer reach in Florida, and this tuck-in acquisition demonstrates our ability to execute on our strategy to grow our Water Treatment business," said Hawkins Chief Executive Officer, Patrick H. Hawkins.

Mr. Hawkins continued, "We have known Dave Symonds for many years and value the strong business and loyal customer following they have built. We look forward to continuing to support those customers and to our continued growth together."

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes and blends products for its Water Treatment, Food & Health Sciences and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 66 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and has approximately 1,200 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Contact:        Jack Shufelt        
                      Investor Relations, M&A and Treasury Director
                      612/617-8582                
                      [email protected]
                      [email protected]


Risks

  • Integration challenges of acquired assets and personnel from Dave Symonds could impact operational efficiency temporarily.
  • Dependence on the water treatment market and regional customer demand fluctuation in Florida could affect revenue growth.
  • Increased competition in the water treatment and specialty ingredients sectors might put pressure on margins and market share.

More from Press Releases

Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund Sep 6, 2026 Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026